Gilead Sciences Inc/ US3755581036 /
| 14/11/2024 17:20:12 | Chg. -0.4300 | Volume | Bid17:20:12 | Ask17:20:12 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 92.2000USD | -0.46% | 1.87 mill. Turnover: 123.4 mill. |
92.1900Bid Size: 200 | 92.2100Ask Size: 200 | 114.43 bill.USD | 3.27% | 20.22 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 4.54 USD | 24.04% |
| EPS Diluted: | 4.50 USD | 23.63% |
| Revenues per Share: | 21.76 USD | -0.52% |
| Book Value per Share: | 18.26 USD | 7.36% |
| Cash Flow per Share: | 6.43 USD | -11.67% |
| Dividend per Share: | 3.00 USD | 2.74% |
| Total | in mill. | |
| Revenues: | 27,116.00 USD | -0.60% |
| Net Income: | 5,665.00 USD | 23.37% |
| Operating Cash Flow: | 8,006.00 USD | - |
| Cash and Cash Equivalents: | 6,085.00 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 20.22 | 17.84 |
| P/S Ratio: | 4.22 | 3.72 |
| P/BV ratio: | 5.03 | 4.44 |
| P/CF Ratio: | 14.29 | 12.61 |
| PEG: | 0.84 | 0.74 |
| Earnings Yield: | 4.94% | 5.60% |
| Dividend Yield: | 3.27% | 3.70% |
| Market Capitalization | ||
| Market Capitalization: | 114.43 bill. USD | 100.94 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 1.25 bill. | |
Profitability
| Gross Profit Margin: | 76.04% |
| EBIT Margin: | 28.05% |
| Net Profit Margin: | 20.89% |
| Return on Equity: | 24.90% |
| Return on Assets: | 9.12% |
Financial Strength
| Liquidity I / Cash Ratio: | 0.54% |
| Liquidity II / Quick Ratio: | 0.95% |
| Liquidity III / Current Ratio: | 1.43% |
| Debt / Equity Ratio: | 1.10% |
| Dynam. Debt / Equity Ratio: | 491.83% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 31/12/2023 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
